| Financial Year |
March 31 2023 |
| Monetary Funds |
213,842,442.59 |
| Held-for-trading Financial Assets |
140,526,256.11 |
| Notes Receivable |
4,014,985.97 |
| Accounts Receivable |
344,774,593.39 |
| Advances to Suppliers |
9,639,580.66 |
| Other Receivables |
13,512,300.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
796,955,070.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,067,114.36 |
| Investment Properties |
890,977.48 |
| Fixed Assetes |
78,265,912.52 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,029,247.90 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
461,504.28 |
| Deferred Income Tax Assets |
21,826,831.97 |
| Other Non-Current Assets |
16,215,829.30 |
| Sub-Total of Non-Current Assets |
138,925,952.59 |
| Total Assets |
935,881,022.91 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
108,635,374.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,179,171.47 |
| Taxes Payable |
39,802,627.12 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,194,088.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,290,318.02 |
| Other Current Liabilities |
1,783,680.13 |
| Sub-Total of Current Liabilities |
209,946,687.01 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,816,758.68 |
| Total Liabilities |
211,763,445.69 |
| Paid-In Capital(Or Share Stock) |
120,381,273.00 |
| Capital Surplus |
364,838,697.79 |
| Surplus Reserve |
23,657,484.63 |
| LESS:Treasury Stock |
6,218,244.72 |
| Undistributed Profits |
217,983,387.56 |
| Minority Stockholder's Interest |
3,385,895.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
720,731,681.48 |
| Owner's Equity（Stockholder's Equity） |
724,117,577.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
935,881,022.91 |
